Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GARLAND

Showing results (311-320 of 325) with videos related to

Pageof 33
Sort By:
Nature Communications|January 9, 2021
Author Correction: High-resolution sampling of beam-driven plasma wakefieldsS Schröder, C A Lindstrøm, S Bohlen, et al.
Circulation|December 18, 2020
Phospholemman Phosphorylation Regulates Vascular Tone, Blood Pressure, and Hypertension in Mice and HumansAndrii Boguslavskyi, Sergiy Tokar, Oleksandra Prysyazhna, et al.
Plos One|July 10, 2024
Correction: A multi-proxy assessment of the impact of environmental instability on Late Holocene (4500-3800 BP) Native American villages of the Georgia coastCarey J Garland, Victor D Thompson, Matthew C Sanger, et al.
Plos One|March 2, 2022
A multi-proxy assessment of the impact of environmental instability on Late Holocene (4500-3800 BP) Native American villages of the Georgia coastCarey J Garland, Victor D Thompson, Matthew C Sanger, et al.
British Journal of Haematology|August 29, 1998
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Blood|December 3, 1998
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Journal of Medicinal Chemistry|January 5, 1996
Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationshipsH C Huang, J J Li, D J Garland, et al.
The Journal of Physiology|June 28, 2024
Thomas (Tom) B. Bolton - a major force in smooth muscle researchAlexander V Zholos, Iain A Greenwood, Rick J Lang, et al.
Journal of Medicinal Chemistry|August 3, 2010
Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathyMarvin J Meyers, Graciela B Arhancet, Susan L Hockerman, et al.
Physical Review Letters|February 9, 2019
Tunable Plasma-Based Energy DechirperR D'Arcy, S Wesch, A Aschikhin, et al.
Pageof 33

Showing results (311-320 of 325) with videos related to

Sort By:
Pageof 33
Nature Communications|January 9, 2021
Author Correction: High-resolution sampling of beam-driven plasma wakefieldsS Schröder, C A Lindstrøm, S Bohlen, et al.
Circulation|December 18, 2020
Phospholemman Phosphorylation Regulates Vascular Tone, Blood Pressure, and Hypertension in Mice and HumansAndrii Boguslavskyi, Sergiy Tokar, Oleksandra Prysyazhna, et al.
Plos One|July 10, 2024
Correction: A multi-proxy assessment of the impact of environmental instability on Late Holocene (4500-3800 BP) Native American villages of the Georgia coastCarey J Garland, Victor D Thompson, Matthew C Sanger, et al.
Plos One|March 2, 2022
A multi-proxy assessment of the impact of environmental instability on Late Holocene (4500-3800 BP) Native American villages of the Georgia coastCarey J Garland, Victor D Thompson, Matthew C Sanger, et al.
British Journal of Haematology|August 29, 1998
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Blood|December 3, 1998
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Journal of Medicinal Chemistry|January 5, 1996
Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationshipsH C Huang, J J Li, D J Garland, et al.
The Journal of Physiology|June 28, 2024
Thomas (Tom) B. Bolton - a major force in smooth muscle researchAlexander V Zholos, Iain A Greenwood, Rick J Lang, et al.
Journal of Medicinal Chemistry|August 3, 2010
Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathyMarvin J Meyers, Graciela B Arhancet, Susan L Hockerman, et al.
Physical Review Letters|February 9, 2019
Tunable Plasma-Based Energy DechirperR D'Arcy, S Wesch, A Aschikhin, et al.
Pageof 33